Overview of Pivotal Studies for Prostate Cancer Risk Reduction, Past and Present

Keyphrases

• Prostate Cancer Risk 100%
• Dutasteride 100%
• Cancer Risk Reduction 100%
• Prostate Cancer 80%
• 5ARI 60%
• Quality of Life 40%
• Disease Progression 20%
• Long Latency 20%
• Age of Onset 20%
• Prostate Cancer Prevention Trial 20%
• Finasteride 20%
• Risk Reduction 20%
• High Prevalence 20%
• Prevention Strategies 20%
• Expectant Management 20%
• Risk Disease 20%
• Healthcare 20%
• Disease Prevention 20%
• Patient Health 20%
• Politicians 20%
• Recurrent Cancer 20%
• Clinical Progression 20%
• Patient Quality 20%
• Localized Prostate Cancer 20%
• Rising Prostate-specific Antigen 20%
• Ongoing Trials 20%
• 5α-reductase Inhibitors 20%
• Period Prevalence 20%
• Risk Reduction Strategies 20%
• Management Experiment 20%
• Therapeutic Assessment 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Dutasteride 50%
• Disease 20%
• Prevalence 20%
• Finasteride 10%
• Prostate Specific Antigen 10%
• Side Effect 10%
• Disease Exacerbation 10%
• Cancer Recurrence 10%
• Oxidoreductase 10%
• Onset Age 10%